The Nifty index has shown resilience amid a volatile market environment, according to Nagaraj Shetti, a seasoned analyst at HDFC Securities. In recent trading sessions, the Nifty has demonstrated a technical pullback, which Shetti insists is not indicative of a broader trend reversal. Instead, it suggests the formation of a higher bottom, providing a strong support zone between 23,400 and 23,500 points. Investors should keep an eye on the 24,100 mark, as surpassing this level could set the stage for a near-term target of 24,500.
In this context, Shetti has identified two stocks that present promising breakout opportunities: Glenmark Pharmaceuticals and Oberoi Realty. Glenmark Pharmaceuticals, a notable player in the healthcare sector, is recommended with a target price of Rs 2,310 and a stop loss at Rs 2,150. This pharmaceutical giant is poised to capitalize on the growing demand for healthcare solutions, driven by both domestic and international markets.
Oberoi Realty, a significant entity in the real estate sector, is also on Shetti's radar. With a target price of Rs 1,800 and a stop loss at Rs 1,630, Oberoi Realty is expected to benefit from the ongoing recovery in the real estate market. The company's strategic projects and robust execution capabilities make it a compelling choice for investors seeking exposure to the real estate sector.
For Indian investors, these insights offer a strategic opportunity to navigate the current market landscape. As the Nifty stabilizes, identifying breakout stocks like Glenmark Pharmaceuticals and Oberoi Realty can provide a tactical edge in portfolio management. Investors should remain vigilant and consider these recommendations as part of a diversified investment approach.
